We and others have previously reported that breast NETs occur generally in older women, they are almost solely oestrogen receptor (ER)-positive and human epidermal growth factor 2 (HER2)-negative, and their prognosis is slightly poorer than that of invasive ductal carcinomas (IDCs) of the breast [4–7]. This evidence concerns the gene ERBB2 and breast neuroendocrine neoplasm.